diatrizoate meglumine has been researched along with Heart Valve Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, V; Bloomquist, JN; Higgins, CB; Lew, W; Mancini, GB; Shabetai, R; Slutsky, RA; Stein, JB | 1 |
| Bilotta, F; Caretta, Q; Marino, B; Mercanti, C; Reale, A; Scibilia, G; Voci, P | 1 |
| Bellandi, M; Benedini, G; Cucchini, F; Ettori, F; Leonzi, O; Niccoli, L; Visioli, O | 1 |
| Akin, JR; Chiu, D; Gertz, EW; Hu, C; Wisneski, JA | 1 |
| de Boo, TM; Fast, JH; Heystraten, FM; Lemmens, WA; Uyen, GJ | 1 |
2 trial(s) available for diatrizoate meglumine and Heart Valve Diseases
| Article | Year |
|---|---|
Hemodynamic and electrocardiographic effects in man of a new nonionic contrast agent (iohexol): advantages over standard ionic agents.
Topics: Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Diatrizoate Meglumine; Double-Blind Method; Electrocardiography; Heart; Heart Valve Diseases; Heart Ventricles; Hemodynamics; Humans; Iodobenzoates; Iohexol; Middle Aged; Triiodobenzoic Acids | 1983 |
Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
Topics: Aged; Angiocardiography; Arrhythmias, Cardiac; Clinical Trials as Topic; Contrast Media; Coronary Disease; Diatrizoate; Diatrizoate Meglumine; Double-Blind Method; Drug Combinations; Electrocardiography; Heart Valve Diseases; Hemodynamics; Humans; Iopamidol; Iothalamic Acid; Male; Middle Aged; Pain; Random Allocation; Thorax | 1985 |
3 other study(ies) available for diatrizoate meglumine and Heart Valve Diseases
| Article | Year |
|---|---|
In vitro development and clinical applications of sonicated echo contrast agents.
Topics: Albumins; Arterial Occlusive Diseases; Contrast Media; Coronary Disease; Diatrizoate Meglumine; Echocardiography; Forecasting; Heart Valve Diseases; Humans; Iopamidol; Microspheres; Sonication | 1991 |
Iopamidol a new contrast agent in angiocardiography. Experimental and clinical experience in comparison with a commonly used contrast medium.
Topics: Angiocardiography; Animals; Contrast Media; Coronary Angiography; Coronary Disease; Diatrizoate Meglumine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Drug Tolerance; Heart; Heart Valve Diseases; Humans; In Vitro Techniques; Iopamidol; Iothalamic Acid; Rabbits | 1986 |
Short-term hemodynamic effects of diatrizoate and ioxaglate contrast media in left ventriculography.
Topics: Adult; Aged; Blood Pressure; Cineangiography; Contrast Media; Coronary Disease; Diatrizoate; Diatrizoate Meglumine; Electrocardiography; Female; Heart Rate; Heart Valve Diseases; Heart Ventricles; Hemodynamics; Humans; Iodobenzoates; Ioxaglic Acid; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Triiodobenzoic Acids | 1985 |